EUVIMEDOdkrijte EUVIMED
Open access · CC BY 4.0

Transperineal laser ablation as treatment for benign prostatic obstruction: Safety, feasibility and functional outcomes—A pilot study

Rob van Kollenburg, Luigi van Riel, Paul Bloemen, Theo de Reijke, Harrie Beerlage, Daniel de Bruin, Jorg Oddens

BJUI Compass · 2024-01 · 5 (1) · 52-59

DOI: 10.1002/bco2.278 ↗

At a glance

Journal article in BJUI Compass, published online on 2023-08-24. Written by Rob van Kollenburg and 6 co-authors. Institution: Urology Amsterdam University Medical Centres Amsterdam The Netherlands. Cited 14 times so far (Crossref); 21 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Standard surgical treatment for lower urinary tract symptoms (LUTS) due to benign prostatic obstruction (BPO) requires anaesthesia and hospitalization. Transperineal laser ablation (TPLA) is a novel minimally invasive treatment for BPO, which has been performed using local anaesthetics and conscious sedation.

Objectives

The aim of this study is to assess safety, feasibility and functional outcomes of TPLA for the treatment of LUTS in men fit also for standard surgery.

Methods

This prospective, multicentre, interventional pilot study included 20 patients. Eligible patients were men ≥40 years of age, with urodynamically proven bladder outlet obstruction, a peak urinary flow of 5–15 mL/s and a prostate volume of 30–120 cc. All subjects underwent Soractelite™ TPLA using the Echolaser® X4 system. Two to four fibres were placed in the prostate, whereafter laser light induced coagulative necrosis. Twelve months of follow‐up included uroflowmetry, an ultrasound of the prostate and PROMs (IPSS and IIEF).

Results

Twenty patients were treated with TPLA using local anaesthetics and optional sedation. Sixteen patients were treated in an outpatient setting, using only local anaesthetics in 12 of them; four were treated in the operating room, whereof two under general anaesthesia. No device related adverse events occurred, nor did any grade ≥3 adverse events during follow‐up. Post‐TPLA, 10 men continued spontaneous voiding, and 10 men developed a urinary retention treated by a temporary indwelling catheter for 15.2 ± 3.5 days. At 12 months, Qmax improved from 9.7 ± 3.5 to 14.9 ± 6.0 ( p = 0.015), IPSS improved from 21.3 ± 5.2 to 10.9 ± 5.5 ( p < 0.0001), QoL improved from 4.9 ± 0.9 to 1.9 ± 1.1 ( p < 0.0001), IIEF‐15 total score remained stable and 11/13 patients (85%) preserved antegrade ejaculation.

Conclusions

TPLA is a safe and feasible treatment for men with LUTS due to BPO. TPLA can be performed in an outpatient setting under only local anaesthetics. Functional and quality of life outcomes improved significantly at 12 months, and erectile function remained stable.

Subjects

Author keywords

benign prostatic hyperplasiabenign prostatic obstructionlaser ablationlower urinary tract symptomsminimal invasive treatmenttransperineal laser ablation

Authors and institutions

  • Urology Amsterdam University Medical Centres Amsterdam The Netherlands.
  • Biomedical Engineering and Physics Amsterdam University Medical Centres Amsterdam The Netherlands.

Cite

APA

van Kollenburg, R., van Riel, L., Bloemen, P., de Reijke, T., Beerlage, H., de Bruin, D., & Oddens, J. (2024). Transperineal laser ablation as treatment for benign prostatic obstruction: Safety, feasibility and functional outcomes—A pilot study. BJUI Compass, 5(1), 52-59. https://doi.org/10.1002/bco2.278

Vancouver

van Kollenburg R, van Riel L, Bloemen P, de Reijke T, Beerlage H, de Bruin D, et al. Transperineal laser ablation as treatment for benign prostatic obstruction: Safety, feasibility and functional outcomes—A pilot study. BJUI Compass. 2024;5(1):52-59. doi:10.1002/bco2.278

BibTeX
@article{vanKollenburg2024,
  author = {van Kollenburg, Rob and van Riel, Luigi and Bloemen, Paul and de Reijke, Theo and Beerlage, Harrie and de Bruin, Daniel and Oddens, Jorg},
  title = {Transperineal laser ablation as treatment for benign prostatic obstruction: Safety, feasibility and functional outcomes—A pilot study},
  journal = {BJUI Compass},
  year = {2024},
  volume = {5},
  number = {1},
  pages = {52--59},
  doi = {10.1002/bco2.278}
}
Start for free →